Status:
COMPLETED
An Observational Study of TNKase in Patients Enrolled in the National Registry of Myocardial Infarction 4 and 5 (POST)
Lead Sponsor:
Genentech, Inc.
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
Brief Summary
The POST study comprised patients whose data were entered into the NRMI 4 and 5 databases. NRMI is a prospective, observational study of patients presenting with AMI in the United States. NRMI was lau...
Eligibility Criteria
Inclusion
- Presence of LBBB or ST-segment elevation (new or of unknown duration)
- ICD-9-CM discharge code of 410.X1
- Treatment with one of the following regimens: TNKase; Other thrombolytic regimens; No initial reperfusion
Exclusion
- Patients who were transferred out of the facility
- Patients with pending data clarification forms on fields related to study variables
Key Trial Info
Start Date :
September 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2006
Estimated Enrollment :
253668 Patients enrolled
Trial Details
Trial ID
NCT00669045
Start Date
September 1 2000
End Date
March 31 2006
Last Update
February 15 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.